| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A pilot study of oral l-arginine in cystic fibrosis
|
Everard, M.L.
|
|
2005
|
4 |
1 |
p. 67-69
3 p.
|
article
|
| 2 |
Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous ΔF508 controls
|
McCormick, Jonathan
|
|
2005
|
4 |
1 |
p. 53-58
6 p.
|
article
|
| 3 |
Associations between clinical variables and quality of life in adults with cystic fibrosis
|
Gee, Louise
|
|
2005
|
4 |
1 |
p. 59-66
8 p.
|
article
|
| 4 |
Docosahexaenoic acid trials in cystic fibrosis: A review of the rationale behind the clinical trials
|
Van Biervliet, S.
|
|
2005
|
4 |
1 |
p. 27-34
8 p.
|
article
|
| 5 |
European cystic fibrosis society consensus on standards—a roadmap to “best care”
|
Littlewood, J.M.
|
|
2005
|
4 |
1 |
p. 1-5
5 p.
|
article
|
| 6 |
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study
|
Hansen, Christine Rønne
|
|
2005
|
4 |
1 |
p. 35-40
6 p.
|
article
|
| 7 |
Prospective evaluation of emerging bacteria in cystic fibrosis
|
Steinkamp, G.
|
|
2005
|
4 |
1 |
p. 41-48
8 p.
|
article
|
| 8 |
Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection
|
Janahi, I.A.
|
|
2005
|
4 |
1 |
p. 71-73
3 p.
|
article
|
| 9 |
Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis
|
Nadesalingam, Kavitha
|
|
2005
|
4 |
1 |
p. 49-52
4 p.
|
article
|
| 10 |
Standards of care for patients with cystic fibrosis: a European consensus
|
Kerem, Eitan
|
|
2005
|
4 |
1 |
p. 7-26
20 p.
|
article
|
| 11 |
The Rossi award
|
Döring, Gerd
|
|
2005
|
4 |
1 |
p. 75-
1 p.
|
article
|
Journal description